About Retham Technologies
Retham Technologies is a biotech company that provides a diagnosis of heparin induced thrombocytopenia by enabling rapid HIT testing.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Seed
Global Headquarters
Wauwatosa, United States
Tracked Since
Oct 2, 2026
Web & Domain Identity
Official Website
rethamtechnologies.com
Domain Registered Date
May 19, 2017
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $1,500,000 · Seed
linkedin.com
- Milestone
Website domain registered
rethamtechnologies.com
Investors & Backers
Golden Angels Investors
Milwaukee Venture Partners
National Institutes of Health
SBIR Advance
Talents Fund
Funding History
Seed
· Sep 15, 2026
$1,500,000 linkedin.com
Founders & Leadership
Anand Padmanabhan
Founder
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026